Company
Headquarters: New Taipei City, Taiwan
CEO: Mr. Yu Ran Chou
TW$9.38 Billion
TWD as of July 1, 2024
US$288.0 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $154.23 B |
| EssilorLuxottica SA | $98.99 B |
| Becton, Dickinson and Company | $65.82 B |
| Alcon Inc. | $43.72 B |
| HOYA Corp | $42.76 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
St.Shine Optical Co.,Ltd. designs, manufactures, markets, and supplies contact lens in Taiwan and internationally. The company's product portfolio includes daily disposable, frequent replacement spherical, aspheric frequent replacement, toric frequent replacement, color, and silicone hydrogel soft contact lens, as well as various cast-molding products. It offers its products for myopic and hyperopic patients for the correction of astigmatism. The company was formerly known as First Optical Co., Ltd. and changed its name to St.Shine Optical Co.,Ltd. in 1986. St.Shine Optical Co.,Ltd. was founded in 1981 and is based in New Taipei City, Taiwan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
St.Shine Optical Co.,Ltd. has the following listings and related stock indices.
Stock: TWSE: 1565 wb_incandescent